Bamboos Health Care Posts Lower Interim Profit and Scraps Dividend

An announcement from Bamboos Health Care Holdings Ltd ( (HK:2293) ) is now available.

Bamboos Health Care Holdings Ltd, a Hong Kong-based healthcare services provider, reported interim results for the six months ended 31 December 2025 that reflect softer performance versus the prior year. The company’s business remains centered on healthcare-related services and products, with revenue derived largely from customer contracts in its home market.

Revenue for the period fell 11.6% year-on-year to HK$34.9 million, while profit before tax declined 17.8% to HK$10.6 million as employee and other operating expenses weighed on margins. Profit attributable to shareholders slipped 7.9% to HK$9.3 million, and the board opted not to declare an interim dividend, reversing last year’s payout and signaling a more cautious capital stance amid moderating earnings.

The most recent analyst rating on (HK:2293) stock is a Buy with a HK$0.50 price target. To see the full list of analyst forecasts on Bamboos Health Care Holdings Ltd stock, see the HK:2293 Stock Forecast page.

More about Bamboos Health Care Holdings Ltd

Bamboos Health Care Holdings Ltd is a Hong Kong-listed company operating in the healthcare services sector. The group provides healthcare-related services and products, generating revenue primarily from contracts with customers in its core healthcare operations in Hong Kong.

Average Trading Volume: 92,609

Technical Sentiment Signal: Sell

Current Market Cap: HK$201.2M

For an in-depth examination of 2293 stock, go to TipRanks’ Overview page.